My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
February 2016
FROM THE PRESIDENT
Stewardship: Putting ID at the Helm, and Giving You the Tools You Need

IDSA has a clear strategic objective: To position ID specialists as the leaders of antimicrobial stewardship programs across the health care system. Several initiatives are well-underway to promote the benefits of ID leadership in stewardship programs, and a host of resources is available to help you develop and lead an ASP in your health care setting. Whether or not you work in a hospital setting, the anticipated CMS requirement for ASPs in acute care settings is important to the field and will very likely impact your work.

TOP STORIES
Zika Virus: IDSA Weighs In
On Feb. 1, the World Health Organization (WHO) declared Zika virus to be an international public health emergency, which now invests WHO with enhanced authority to focus high-level attention and mobilize resources internationally.  IDSA is monitoring the outbreak, relaying guidance to clinicians, and providing input to the media and policymakers.
IDSA Names Robert T. “Chip” Schooley Next Editor of CID

The Infectious Diseases Society of America (IDSA) has named Robert T. “Chip” Schooley, MD, FIDSA, to be editor-in-chief of the Society’s prestigious peer-reviewed journal Clinical Infectious Diseases (CID). Dr. Schooley’s term will begin in January 2017, upon the retirement of the journal’s current editor-in-chief, Sherwood Gorbach, MD, FIDSA, who has led the journal with distinction since 2000.  Ferric C. Fang, MD, will serve as CID’s next deputy editor-in-chief.

Nominate Your Colleague for an IDSA or HIVMA Award

IDSA, HIVMA and the IDSA Education and Research Foundation (ERF) are now accepting nominations for the 2016 Society Awards and the HIVMA Awards, which honor outstanding achievement and up-and-coming leaders in the field. Award recipients will be honored at IDWeek in New Orleans, Oct. 26-30.

IDSA Journal Club

Antibiotics: Meant to Heal, but also Conferring Risk for C. difficile; Is the Joint Involved? Staphylococcus aureus Bacteremia among Patients with Joint Prostheses; Isavuconazole: A New Alternative for the Treatment of Invasive Aspergillosis; A Pan-Hepatitis C Medication with Excellent Safety and Efficacy.

Upcoming dates to remember


The combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct. 26-30, 2016, in New Orleans. See you there!

PATIENT CARE AND SCIENCE
Update on Antimicrobial Susceptibility Testing from the Clinical and Laboratory Standards Institute (CLSI)
CLINICAL PRACTICE MANAGEMENT
Avoid 2017 Medicare EHR Incentive Program Payment Penalties
How to Avoid Physicians Quality Reporting System (PQRS) Payment Penalties in 2018
POLICY AND ADVOCACY
Federal Budgets: What Lies Ahead in Funding for HIV/ID Priorities
Efforts Continue on Pyrimethamine Pricing Issues
IDSA Pushes for Antibiotics and Diagnostics R&D Incentives on Capitol Hill
Physician-Scientist Diversity: IDSA Weighs in with NIH
IDSA Expresses Concerns Over Limited Data on Antibiotic Use in Agriculture
GLOBAL ID
Science Speaks
IDSA Center for Global Health Policy Releases Report from Mozambique
EDUCATION AND RESOURCES
IDSA, HIVMA Programs Give Medical Students a First-hand Look at ID, HIV
IDWeek YouTube Channel Promotes the Specialty of ID
YOU AND YOUR COLLEAGUES
Members on the Move
Member Report
FROM THE PRESIDENT
Stewardship: Putting ID at the Helm, and Giving You the Tools You Need
TOP STORIES
Zika Virus: IDSA Weighs In
IDSA Names Robert T. “Chip” Schooley Next Editor of CID
Nominate Your Colleague for an IDSA or HIVMA Award
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here